IRIS
BIANCO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.797
AS - Asia 1.725
EU - Europa 959
SA - Sud America 215
Continente sconosciuto - Info sul continente non disponibili 110
AF - Africa 36
OC - Oceania 1
Totale 4.843
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.629
SG - Singapore 829
IT - Italia 758
HK - Hong Kong 366
CN - Cina 245
BR - Brasile 173
BD - Bangladesh 125
CA - Canada 70
VN - Vietnam 62
GB - Regno Unito 56
IN - India 33
DE - Germania 26
ZA - Sudafrica 24
CR - Costa Rica 23
NL - Olanda 19
AT - Austria 18
FR - Francia 15
AR - Argentina 13
GP - Guadalupe 11
PK - Pakistan 11
UA - Ucraina 10
MX - Messico 9
CW - ???statistics.table.value.countryCode.CW??? 8
HN - Honduras 8
ID - Indonesia 8
TR - Turchia 8
VE - Venezuela 8
EC - Ecuador 7
UZ - Uzbekistan 7
BB - Barbados 6
EE - Estonia 6
FI - Finlandia 6
IQ - Iraq 6
NI - Nicaragua 6
PR - Porto Rico 6
SA - Arabia Saudita 6
SV - El Salvador 6
IE - Irlanda 5
JM - Giamaica 5
TT - Trinidad e Tobago 5
CL - Cile 4
CZ - Repubblica Ceca 4
ES - Italia 4
KE - Kenya 4
PL - Polonia 4
RO - Romania 4
RU - Federazione Russa 4
AZ - Azerbaigian 3
CO - Colombia 3
GR - Grecia 3
IR - Iran 3
MA - Marocco 3
RS - Serbia 3
SE - Svezia 3
UY - Uruguay 3
AL - Albania 2
BZ - Belize 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GT - Guatemala 2
KR - Corea 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KY - Cayman, isole 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 4.741
Salva come PNG Salva come JPEG
Città #
Hong Kong 365
Council Bluffs 314
Ashburn 247
San Jose 174
Milan 145
Singapore 96
Rome 70
Santa Clara 63
New York 47
Princeton 35
Naples 32
North Bergen 32
Abbeville 27
Beijing 24
Florence 23
Ho Chi Minh City 22
Los Angeles 22
Turin 21
Bologna 20
Mumbai 19
San José 17
Bari 16
Dallas 13
São Paulo 13
Miano 12
Figino 11
Montreal 10
Palermo 10
Cagliari 9
Haiphong 9
Hanoi 9
London 9
Catania 8
Rio de Janeiro 8
Vienna 8
Willemstad 8
Brooklyn 7
Buffalo 7
Chicago 7
Denver 7
Lahore 7
Miami 7
Nuremberg 7
Phoenix 7
Tashkent 7
Belo Horizonte 6
Bridgetown 6
Frankfurt am Main 6
Genoa 6
Houston 6
Pointe-à-Pitre 6
Toronto 6
Atlanta 5
Johannesburg 5
Lappeenranta 5
Managua 5
Modena 5
Philadelphia 5
Quito 5
Riyadh 5
San Salvador 5
Seattle 5
Tampa 5
Taranto 5
The Bronx 5
Baghdad 4
Brasília 4
Caracas 4
Charlotte 4
Da Nang 4
Padua 4
Reggio Calabria 4
São Bernardo do Campo 4
Woodbridge 4
Baltimore 3
Boston 3
Brescia 3
Capaccio Paestum 3
Detroit 3
Dhaka 3
Edmonton 3
Las Vegas 3
Lecce 3
Lissone 3
Lucca 3
Mexico City 3
Montevideo 3
Nairobi 3
Newark 3
Niagara Falls 3
Orem 3
Porto Alegre 3
Prague 3
Queens 3
Reggio Emilia 3
Salvador 3
San Pedro Sula 3
Santo André 3
Sassari 3
St Louis 3
Totale 2.252
Salva come PNG Salva come JPEG
Nome #
Ceftazidime-Avibactam (C/A) Resistant, Meropenem Sensitive KPC-Producing Klebsiella pneumoniae in ICU Setting: We Are What We Are Treated with? 125
Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey 116
Activity of cefiderocol and synergy of novel β-lactam-β-lactamase inhibitor-based combinations against metallo-β-lactamase-producing gram-negative bacilli: insights from a two-year study (2019-2020) 82
Enterobacterales carrying chromosomal AmpC β-lactamases in Europe (EuESCPM): Epidemiology and antimicrobial resistance burden from a cohort of 27 hospitals, 2020–2022 77
Bloodstream Infections by Pantoea Species: Clinical and Microbiological Findings from a Retrospective Study, Italy, 2018–2023 77
Comparative virulence of seasonal viruses responsible for lower respiratory tract infections: a southern European multi-centre cohort study of hospital admissions 75
Performance evaluation of Bruker UMIC® microdilution panel and disc diffusion to determine cefiderocol susceptibility in Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Achromobacter xylosoxidans and Burkolderia species 73
Combination of Poly(ε-Caprolactone) Biomaterials and Essential Oils to Achieve Anti-Bacterial and Osteo-Proliferative Properties for 3D-Scaffolds in Regenerative Medicine 72
Bacterial etiology and antimicrobial resistance trends in ocular infections: A 30-year study, Turin area, Italy 72
Detection of volatile organic compounds as new paradigm to accelerate antimicrobial susceptibility testing: performance evaluation of VITEK® REVEAL™ 72
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019-2021): emergence of complex resistance phenotypes 68
RICERCA DI BARTONELLA HENSELAE IN DIFFERENTI CAMPIONI CLINICI DI PAZIENTI CON SOSPETTA MALATTIA DA GRAFFIO DI GATTO MEDIANTE INDAGINE MOLECOLARE E SIEROLOGICA 67
Clinical and microbiological features of positive blood culture episodes caused by non-fermenting gram-negative bacilli other than Pseudomonas and Acinetobacter species (2020–2023) 63
Changes in KPC-producing Klebsiella pneumoniae susceptibility from the pre- to ceftazidime-avibactam era 63
Synergistic Effect of Clinically Available Beta-Lactamase Inhibitors Combined with Cefiderocol against Carbapenemase-Producing Gram-Negative Organisms 63
Bloodstream infection by two subpopulations of Klebsiella pneumoniae ST1685 carrying KPC-33 or KPC-14 following ceftazidime/avibactam treatment: Considerations regarding acquired heteroresistance and choice of carbapenemase detection assay 62
Increased blaKPC Copy Number and OmpK35 and OmpK36 Porins Disruption Mediated Resistance to Imipenem/ Relebactam and Meropenem/Vaborbactam in a KPC-Producing Klebsiella pneumoniae Clinical Isolate 62
Disc Diffusion and ComASP® Cefiderocol Microdilution Panel to Overcome the Challenge of Cefiderocol Susceptibility Testing in Clinical Laboratory Routine 61
Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol 60
MALDI-TOF MS-Based Approaches for Direct Identification of Gram-Negative Bacteria and BlaKPC-Carrying Plasmid Detection from Blood Cultures: A Three-Year Single-Centre Study and Proposal of a Diagnostic Algorithm 59
Burden of primary influenza and respiratory syncytial virus pneumonia in hospitalized adults: insights from a two-year multi-centre cohort study (2017-2018) 58
An Observational Study of MDR Hospital-Acquired Infections and Antibiotic Use during COVID-19 Pandemic: A Call for Antimicrobial Stewardship Programs 56
Ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in KPC-producing Klebsiella pneumoniae infections: A case series 56
Carbapenemase detection testing in the era of ceftazidime/avibactam-resistant KPC-producing Enterobacterales: A 2-year experience 55
Multicentre Evaluation of the EUCAST Rapid Antimicrobial Susceptibility Testing (RAST) Extending Analysis to 16–20 Hours Reading Time 55
A subanalysis of Clostridium perfringens bloodstream infections from a 5-year retrospective nationwide survey (ITANAEROBY) 55
In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study (2022–23) 55
Accuracy of the ELITe MGB® assays for the detection of carbapenemases, CTX-M, Staphylococcus aureus and mecA/C genes directly from respiratory samples 55
In vitro activity of cefiderocol against ceftazidime‑avibactam susceptible and resistant KPC‑producing Enterobacterales: cross‑resistance and synergistic effects 54
Rapid determination of ceftazidime/avibactam susceptibility of carbapenemase-producing Enterobacterales directly from blood cultures: a comparative evaluation of EUCAST disc diffusion RAST and direct Etest® RAST 54
Outbreak of ceftazidime-avibactam resistant KPC-producing Klebsiella pneumoniae in a COVID-19 Intensive Care Unit, Italy: urgent need for updating diagnostic protocols of surveillance cultures 54
Nanofilm: a new drug delivery system to counteract Multi Drug Resistant Gram negative bacteria infections 52
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 52
Prevalence, persistence, and factors associated with sars-cov-2 igg seropositivity in a large cohort of healthcare workers in a tertiary care university hospital in northern italy 52
From Forgotten Pathogen to Target for New Vaccines: What Clinicians Need to Know about Respiratory Syncytial Virus Infection in Older Adults 52
Assessment of rapid direct E-test on positive blood culture for same-day antimicrobial susceptibility 51
Colistin: Lights and Shadows of an Older Antibiotic 51
Prevalence and Impact on Mortality of Colonization and Super-Infection by Carbapenem-Resistant Gram-Negative Organisms in COVID-19 Hospitalized Patients 50
Ralstonia mannitolilytica bacteraemia: a case report and literature review 50
Ceftazidime-avibactam susceptible to resistant KPC-producing Enterobacterales bloodstream infections: an observational study 50
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations 50
Light Scattering Technology and MALDI-TOF MS in the microbiological fast-track of bloodstream infections: potential impact on antimicrobial treatment choices in a real-life setting 49
Rapid diagnostics and ceftazidime/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy 49
Evaluation of Bartonella henselae by molecular and serological assays in different clinical specimens from patients with suspected cat scratch disease 49
First case of Chryseobacterium gallinarum bloodstream infection: a diagnostic and therapeutic challenge for an emerging pathogen 49
In vitro activity of cefiderocolagainst European Enterobacterales, including isolates resistant to meropenem and recentβ-lactam/β-lactamase inhibitor combinations 48
Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018–2022) 47
In Vivo Emergence of Ceftazidime/Avibactam, Cefiderocol and Aztreonam/Avibactam Cross-Resistance in a Patient With KPC-Producing Klebsiella pneumoniae Infection After Cefiderocol-Based Treatment 47
Fast-track identification of CTX-M-extended-spectrum-β-lactamase- and carbapenemase-producing Enterobacterales in bloodstream infections: implications on the likelihood of deduction of antibiotic susceptibility in emergency and internal medicine departments 47
Meropenem/vaborbactam-based combinations against KPC-producing Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa 47
Ten Years of KPC-Kp Bloodstream Infections Experience: Impact of Early Appropriate Empirical Therapy on Mortality 47
Detection of Carbapenemase and CTX-M Encoding Genes Directly from Bronchoalveolar Lavage Using the CRE and ESBL ELITe MGB Assays: Toward Early and Optimal Antibiotic Therapy Management of Critically Ill Patients with Pneumonia 46
Impact of NG-Test CTX-M MULTI Immunochromatographic Assay on Antimicrobial Management of Escherichia coli Bloodstream Infections 46
Influenza and respiratory syncytial virus infections in the oldest-old continent 45
RESIST-5 O.O.K.N.V. and NG-Test Carba 5 assays for the rapid detection of carbapenemase-producing Enterobacterales from positive blood cultures: a comparative study 45
Development of an EliSPOT assay for HSV-1 and clinical validation in lung transplant patients 45
Severity of RSV infection in Southern European elderly patients during two consecutive winter seasons (2017–2018) 45
Multicentre Surveillance of Candida Species from Blood Cultures during the SARS-CoV-2 Pandemic in Southern Europe (CANCoVEU Project) 44
Detection of antibiotic resistance genes from blood cultures: performance assessment and potential impact on antibiotic therapy management 44
Enhanced Antimicrobial and Antibiofilm Effect of New Colistin-Loaded Human Albumin Nanoparticles 44
The CCM Project “Phenotypic and molecular screening methodologies for the detection of colonizations due to carbapenem-resistant Enterobacterales (CRE)”|Il Progetto CCM “Metodologie di screening fenotipiche e molecolari per il rilevamento delle colonizzazioni da enterobatteri resistenti ai carbapenemi (CRE)” 44
Trueperella bernardiae bloodstream infection following onco-gynaecologic surgery and literature review 44
Direct detection of extended‑spectrum‑β‑lactamase‑producers in Enterobacterales from blood cultures: a comparative analysis 43
IN VITRO DALBAVANCIN ACTIVITY AGAINST CLINICAL ISOLATES OF STAPHYLOCOCCUS SPP. AND SUBSEQUENT INTERACTION WITH HUMAN PHAGOCYTES 43
Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients 43
Multicenter study on the prevalence of colonization due to carbapenem-resistant Enterobacterales strains before and during the first year of COVID-19, Italy 2018–2020 42
Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies 42
Comparison of Three Different Commercial Methods for Fosfomycin Susceptibility Testing in Pseudomonas aeruginosa 42
Occurrence of adenovirus infection and clinical impact in paediatric stem cell transplant recipients 42
Renal Allograft Biopsies with Polyomavirus BK Nephropathy: Turin Transplant Center, 2015–19 42
Rubella serosurvey and factors related to vaccine hesitancy in childbearing women in Italy 42
Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era 41
Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection 41
Exposure to the agricultural fungicide tebuconazole promotes Aspergillus fumigatus cross-resistance to clinical azoles. [Comini S. is the co-first author; Banche G. is the corresponding author; Cuffini A.M. is the co-corresponding author] 41
Staphylococcus aureus from hospital-acquired pneumonia from an Italian nationwide survey: activity of ceftobiprole and other anti-staphylococcal agents, and molecular epidemiology of methicillin-resistant isolates 40
Evaluation of CMV DNA in dried blood spot 40
Integrating rapid diagnostics in Gram-negative bloodstream infections of patients colonized by carbapenemase-producing Enterobacterales 40
Performance Evaluation of BD Phoenix and MicroScan WalkAway plus for Determination of Fosfomycin Susceptibility in Enterobacterales 39
Evaluation of a diagnostic algorithm for rapid identification of Gram-negative species and detection of extended-spectrum β-lactamase and carbapenemase directly from blood cultures 39
Parvimonas micra bacteremia following endoscopic retrograde cholangiopancreatography: A new route of infection 39
Persistently high-level polyomavirus BK replication in the absence of renal function abnormalities in a kidney transplant recipient 39
In vivo development of resistance to novel β-lactam/β-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae infections: a case series 39
In vivo development of cefiderocol resistance in carbapenem-resistant Acinetobacter baumannii associated with the downregulation of a TonB-dependent siderophore receptor, PiuA 39
Evaluation of synergistic activity of plazomicin-based combinations against KPC-producing Klebsiella pneumoniae with complex multidrug resistance phenotypes 39
Implementation of Chromatic Super CAZ/AVI® medium for active surveillance of ceftazidime-avibactam resistance: preventing the loop from becoming a spiral 38
Direct Ethylenediaminetetraaceticacid-Modified β-Lactam Inactivation Method: An Improved Method to Identify Serine-Carbapenemase-, Metallo-β-Lactamase-, and Extended-Spectrum-β-Lactamase-Producing Enterobacterales Directly from Positive Blood Culture 38
Evaluation of BD Phoenix and Microscan WalkAway for determination of fosfomycin susceptibility in Staphylococcus aureus 38
Serological and molecular detection of Bartonella henselae in specimens from patients with suspected cat scratch disease in Italy: A comparative study [*V. Allizond and C. Costa contributed equally to this work; ** G. Banche is the corresponding author] 38
Septic shock due to meropenem- and colistin-resistant Cupriavidus pauculus 37
Evaluation of the Amplex eazyplex SuperBug Acineto test for direct detection of multidrug- resistant Acinetobacter baumannii bloodstream infections in high endemicity settings [S. Comini is the corresponding author] 36
Complete Genome Sequence of a Klebsiella pneumoniae Strain Carrying Novel Variant blaKPC-203, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023 36
Evaluation of the NG-Test CTX-M MULTI immunochromatographic assay for the rapid detection of CTX-M extended-spectrum-ß-lactamases producers from positive blood cultures 34
Direct beta-lactam inactivation method: a new low-cost assay for the rapid detection of carbapenemase- or extended-spectrum- beta-lactamase-producing Enterobacterales directly from positive blood culture bottles 33
Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin 32
Multiplex-PCR Identification of Positive Blood Cultures: Pathogen Epidemiology, Resistance Determinants, and the Economic and Interpretive Cost of Qualitative Rapid Diagnosis 29
Totale 4.843
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.376
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025816 79 2 3 10 7 296 39 13 50 140 54 123
2025/20261.897 285 220 232 171 86 89 144 70 203 76 231 90
2026/20272.130 346 333 252 1.144 55 0 0 0 0 0 0 0
Totale 4.843